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(Wettstein et al., 1991; van Schooten et al., 1992; Kozono
et al., 1994) also have been shown to activate T cell
signal transduction pathways. These experiments have
led to the hypothesis that clustering or aggregation of
T cell receptor components is important for initiation of
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T cell activation, but the mechanism of clustering and
the number and conformation of TCR components in
the activating complex are not clear.Summary
Several studies have attempted to determine the mini-
mal requirements for T cell activation. In one approach,A series of novel chemically defined soluble oligomers
of the human MHC class II protein HLA-DR1 was con- the effects of varying antigen density on T cell activation
was investigated for MHC-peptide complexes incorpo-structed to probe the molecular requirements for initi-
ation of T cell activation. MHC dimers, trimers, and rated into planar bilayers (Fox et al., 1987; Watts, 1988)
and for soluble antigen arrays (Symer et al., 1992). Thesetetramers stimulated T cells, as measured by upregu-
lation of the activation markers CD69 and CD25, and studies helped define a threshold antigen density re-
quired for activation but could not address local valencyby internalization of activated T cell receptor subunits.
Monomeric MHC-peptide complexes engaged T cell requirements at activated T cell receptors. More re-
cently, soluble dimeric MHC-peptide complexes pre-receptors but did not induce activation. For a given
amount of receptor engagement, the extent of activa- pared by antibody-mediated oligomerization of soluble
MHC molecules (Abastado et al., 1995) or by fusion oftion was equivalent for each of the oligomers and cor-
related with the number of T cell receptor cross-links MHC extracellular domains with antibody Fc portions
(Casares et al., 1999; Hamad et al., 1998) were showninduced. These results suggest that formation or re-
arrangement of a T cell receptor dimer is necessary to induce various T cell activation or differentiation pro-
cesses, suggesting that dimers could be sufficient forand sufficient for initiation of T cell signaling.
activation. However, using a series of oligomeric MHC-
peptide complexes produced by streptavidin-mediatedIntroduction
cross-linking of biotinylated MHC proteins and measur-
ing extracellular acidification and Ca21 flux, Boniface etT cells are activated upon encounter with another cell
al. (1998) reported that trimers were the minimal activat-that carries on its surface appropriate complexes of
ing species.major histocompatibility complex (MHC) protein and
At odds with these results, some studies have sug-peptide antigen (Germain, 1994; Davis et al., 1998). The
gested that under certain conditions monomeric MHC-interaction involves specific recognition of the MHC-
peptide complexes can trigger T cell activation (Jane-peptide complexes by clonotypic T cell receptor (TCR)
way, 1995). Sykulev et al. (1996) used antigen-presentingsubunits, as well as antigen-independent interactions
cells loaded with defined numbers of peptides to acti-between adhesion molecules and other cell surface re-
vate CD81 T cells and concluded that number densitiesceptors from the T cell and the antigen-presenting cell
as low as one peptide per cell were sufficient to activate(Alberola-Ila et al., 1997; Germain and Stefanova, 1999).
a cytolytic T cell response. Delon et al. (1998) reportedDownstream signaling pathways, including formation of
that monomeric soluble MHC-peptide complexes werelarge multicomponent activating clusters (Monks et al.,
able to induce Ca21 flux in T cells that expressed CD8.1998; Grakoui et al., 1999; Rudd, 1999), activation of
Recent characterization of two phenomena associ-cytoplasmic kinase cascades (Wange and Samelson,
ated with MHC-TCR interaction further complicate our1996; Cantrell, 1996; Qian and Weiss, 1997), and specific
view of T cell activation processes. Reich et al. (1997)transcriptional activation leading to cytokine secretion
observed that at high concentrations, MHC-TCR com-and T cell proliferation (Ullman et al., 1990; Glimcher
plexes showed a tendency to aggregate exhibited byand Singh, 1999), have been characterized in detail, but
neither MHC nor TCR protein alone, suggesting thatthe initial molecular events occurring at the juxtaposed
binding of monomeric MHC-peptide complexes couldmembranes that lead to T cell activation are not well
trigger oligomerization of TCR on the surface of T cells.understood. Extracellular antibody-induced clustering
Valitutti et al. (1995) observed that at low antigen densi-of TCR complexes (Bekoff et al., 1986; Janeway, 1995)
ties, single MHC-peptide complexes serially engagedor of chimeric constructs carrying TCR cytoplasmic do-
multiple TCR molecules, using downmodulation of acti-mains (Irving and Weiss, 1991; Letourneur and Klausner,
vated receptors (Zanders et al., 1983) as a way to count1991; Romeo et al., 1992) has been shown to induce
the number of engaged TCR (Itoh et al., 1999). In princi-T cell processes characteristic of interaction with an
ple such serial triggering could allow a single MHC mole-antigen-presenting cell. MHC-peptide complexes incor-
cule on an antigen-presenting cell to cluster TCR on theporated into planar membranes (Watts et al., 1984; Quill
T cell membrane (Sykulev et al., 1996).and Schwartz, 1987) or coated onto plastic surfaces
In this study, the requirements for T cell activation
were investigated in a systematic manner, using a series* To whom correspondence should be addressed (e-mail: stern@
mit.edu). of chemically defined, soluble oligomers of a human
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Figure 1. Design and Construction of Soluble MHC-Peptide Oligomers
(A) Chemical structures of cross-linking reagents used to make MHC-peptide oligomers. All cross-linkers carry maleimide groups for coupling
to cysteine resides introduced into HLA-DR1. Left, fluorescein-labeled, peptide-based cross-linkers for production of MHC dimers (28), trimers
(38), and tetramers (48). Upper right, biotin-labeled dimeric cross-linker for production of higher order streptavidin-linked oligomers (SA8). Lower
right, ribbon diagram of the HLA-DR1-peptide complex (Stern et al., 1994), showing the position of cysteine residues (asterisks) introduced
at the end of either the a or b subunit connecting peptide region. The HLA-DR1 model is shown at approximately 80% of the scale of the
chemical diagrams of the cross-linking reagents. The symbol used throughout the manuscript to refer to each complex is indicated.
(B) Oligomeric HLA-DR1-peptide complexes are stable to SDS-induced chain dissociation, indicating the presence of bound peptide (left
panel), and contain the desired covalent bonds through the b chain as indicated by boiling in SDS (right panel).
(C) Gel filtration traces of purified oligomeric HLA-DR1-Ha peptide complexes exhibit the sizes expected for monomer (18), dimer (28), trimer
(38), and tetramer (48). The profile for molecular weight standards is indicated below the HLA-DR1 traces.
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Figure 2. T Cell Activation by MHC Oligomers
Flow cytometry analysis of CD3 downregulation and CD69 upregulation at 12 hr (top panel) and of CD3 downregulation and CD25 upregulation
at 27 hr (bottom panel) indicates that dimers (350 nM), trimers (460 nM), and tetramers (280 nM) of HLA-DR1-Ha induce activation of the
HA1.7 T cell clone. Monomeric MHC-peptide complexes (1.4 mM) do not cause activation in any of the assays. Activation markers were
detected using phycoerythrin-labeled CD3 (CD3-PE) and allophycocyanin-labeled CD69 or CD25 (CD69-APC, CD25-APC). The entire cell
population was used to calculate the mean fluorescence values shown for these and other oligomer concentrations in Figure 3.
class II MHC protein. MHC binding was measured con- in E. coli (Frayser et al., 1999) in the presence of an
antigenic peptide derived from influenza virus hemag-currently with several T cell activation processes, using
fluorescent labels incorporated into oligomer cross-link- glutinin (Ha) or a control endogenous peptide (A2). Di-
meric, trimeric, and tetrameric complexes of HLA-DR1ing reagents. We find that a dimer of MHC-peptide com-
plexes is necessary and sufficient for initiation of T cell were formed through reaction of the synthetic cross-
linkers with MHC proteins carrying the introduced cyste-activation. MHC-peptide monomers bind but do not ac-
tivate T cells. Quantitative comparisons of binding and ine residue on the b subunit (see Experimental Proce-
dures). Purified cross-linked oligomers exhibited theactivation levels demonstrate that dimers, trimers, and
tetramers activate identically per molecule of MHC expected b subunit covalent cross-links, as judged by
SDS-PAGE (Figure 1B, right panel), and the sizes ex-bound. These results can be used to assess possible
molecular models for initial T cell activation events and pected for soluble monomeric, dimeric, trimeric, and
tetrameric MHC proteins with no tendency to aggregate,support a model in which formation or rearrangement
of a dimer of TCR molecules in the membrane is the as judged by gel filtration chromatography (Figure 1C).
MHC monomers and oligomers all retained the abilityrelevant molecular triggering event in T cell activation.
to tightly bind peptide antigens, as judged by resistance
to SDS-induced chain dissociation at room temperatureResults
(Figure 1B, left panel).
Oligomer Design and Construction
To study the topological requirements for T cell activa- T Cell Activation Induced by MHC-Peptide Oligomers
To evaluate the ability of soluble MHC class II oligomerstion a series of soluble oligomeric complexes of the
human MHC class II protein, HLA-DR1 was constructed. to activate T cells, we used the well-characterized, Ha-
peptide-specific human CD41 T cell clone HA1.7 (LambFor production of oligomers, we chemically synthesized
peptide-based cross-linking reagents containing a fluo- et al., 1982) and measured the ability of the MHC-peptide
complexes to induce a variety of T cell activation pro-rescent label (fluorescein) and two or more thiol-reactive
maleimide groups linked to lysine residues spaced along cesses, including upregulation of the early T cell activa-
tion marker CD69 (Testi et al., 1994), upregulation of thea flexible backbone containing glycine, serine, and glu-
tamic acid (Figure 1A). The nonrepeating backbone se- low-affinity IL-2 receptor CD25 (Waldmann, 1989), and
downregulation of activated T cell receptor (TCR) CD3quence was designed to be water-soluble with little pro-
pensity to form an ordered structure and to provide components (Zanders et al., 1983; Valitutti et al., 1995).
Dimeric, trimeric, and tetrameric complexes of HLA-sufficient length and flexibility to allow pendant MHC
molecules to bind simultaneously to a cell surface. HLA- DR1-Ha induced downregulation of CD3 and upregula-
tion of both CD69 and CD25, as measured by flow cy-DR1 was modified to introduce a cysteine residue at the
C terminus of the extracellular domain of either the a or b tometry (Figure 2). CD69 upregulation was measured at
12 hr, and CD25 upregulation at 27 hr, near the optimumsubunit (Figure 1A). Cys-modified HLA-DR1 complexes
were produced by in vitro folding of subunits expressed levels as determined by a time course of the response
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Figure 3. Concentration Dependence of T Cell Activation by Oligomeric MHC-Peptide Complexes
Dose response of CD3 downregulation (A) and CD69 upregulation (B) at 12 hr and of CD3 downregulation (C) and CD25 upregulation (D) at
27 hr by HLA-DR1-Ha monomers (closed circles), dimers (closed diamonds), trimers (closed triangles), and tetramers (closed squares), shown
as mean fluorescence values and also as molecules per cell for CD3. The dose response of the higher order SA-linked oligomers (X) is
indicated by a dotted line. The response is peptide-specific as tetramers carrying the endogenous peptide A2 (open squares) do not induce
T cell activation. Monomeric HLA-DR1-Ha does not induce T cell activation even at high protein concentrations.
(J.R.C., unpublished data; Hara et al., 1986; Caruso et activated little or no CD3 downregulation, CD69 upregu-
lation, or CD25 upregulation, even at concentrations upal., 1997). Significant CD3 downregulation was observed
at these times as measured simultaneously by multicolor to 2 mM (100 mg/ml). T cell activation was not caused
by the cross-linker itself, as demonstrated by the A2flow cytometry (Figure 2) and also as early as 5 hr (data
not shown). Monomeric HLA-DR1-Ha complexes did not peptide tetramer control. At higher concentrations, trace
activation signals were observed for both specific (Hastimulate any of the activation responses in these
assays. The monomer preparations were not damaged peptide) and nonspecific (A2 peptide) MHC monomers
(data not shown).or otherwise intrinsically unable to activate T cells, as
we observed strong T cell activation with HLA-DR1-
Ha monomers aggregated by immobilization on plastic
microtiter plates (data not shown), as previously ob- Oligomer Binding and Avidity
The more potent activation induced by the higher-orderserved in other systems (Wettstein et al., 1991; van
Schooten et al., 1992; Kozono et al., 1994). oligomers could be explained if they bound more effi-
ciently to the T cell surface. Because avidity increasesTo determine the dose response of the activation, a
wide range of oligomer concentrations was tested for with increased valency of binding, at a given MHC con-
centration more MHC protein would be bound for aeach of the activation markers (Figure 3). In each assay,
MHC-peptide tetramers (squares) activated more po- larger oligomer as compared to a smaller oligomer. Ad-
ditionally, the inability of MHC monomers to induce acti-tently than trimers (triangles), and trimers more potently
than dimers (diamonds). The oligomer concentration vation could be the result of a very weak binding affinity,
such that few monomers might be bound to the T cellneeded to induce a given level of response, as well as
the maximum response observed, varied systematically surface even at the relatively high concentrations tested.
To evaluate the relative ability of the various oligomerswith oligomer size. This pattern is consistent whether
the oligomer concentration is considered in terms of the to bind to T cells, we measured oligomer binding concur-
rently with activation, using fluorescein incorporatednumber of molecules of oligomers (Figure 3) or as the
total number of MHC molecules (data not shown). The into the cross-linking reagents. Oligomeric MHC-pep-
tide complexes were observed to bind to HA1.7 T cells inobserved T cell responses to the oligomers were antigen
specific, as tetramers complexed with the nonspecific a dose-dependent manner, with higher order oligomers
exhibiting more binding at lower concentrations relativeendogenous peptide A2 showed no activation (open
squares). Monomeric MHC-peptide complexes (circles) to smaller oligomers (Figure 4A). Fluorescein-labeled
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probe. These SA-PE tetramers exhibit strong, pH-inde-
pendent fluorescence from the R-phycoerythrin conju-
gate and bind in an antigen-specific manner to HA1.7
T cells (T. O. C. unpublished data). We incubated T cells
with a fixed concentration of SA-PE tetramers (35 nM)
and varying concentrations of MHC-peptide oligomers
and monomers in a 3 hr competitive binding assay (Fig-
ure 4B). Although the SA-PE tetramers may be internal-
ized during even this brief incubation, the relative ability
of soluble oligomers to compete for SA-PE tetramer
binding sites will reflect their relative avidity. The chemi-
cally cross-linked tetramers competed most efficiently
for binding (IC50 z100 nM), followed by the trimers (z300
nM) and dimers (z1.8 mM). MHC tetramers carrying the
nonspecific peptide A2 did not compete for binding.
Monomeric HLA-DR1-Ha complexes exhibited clear
competitive binding behavior, with an IC50 of z3.4 mM.
Thus, as observed in the direct binding assay, mono-
meric MHC molecules were able to occupy a substantial
number of T cell receptors (.30% of the total TCR at
1 mM; Figures 4A and 4B) under conditions where es-
sentially no T cell activation was observed (Figures 2
and 3).
Correlation of Activation Markers
To investigate the relative ªqualityº of the activation sig-
Figure 4. Oligomeric MHC-Peptide Complexes Bind to HA1.7 T nal induced by oligomers of different sizes, we cross-
Cells
correlated the levels of activation observed in the differ-
(A) Direct binding of MHC-peptide oligomers, measured at 27 hr ent activation assays. To extend the range of oligomer
using fluorescein labels incorporated into cross-linking reagents.
sizes investigated, we prepared higher order MHC oligo-For this experiment, monomers were labeled using a thiol-specific
mers using biotinylated MHC dimers (Figure 1A) clus-fluorescein derivative.
(B) Competitive binding. Various concentrations of MHC-peptide tered by streptavidin (SA). These SA oligomers were
oligomers or monomers were used to compete for binding in a 3 hr effective in inducing CD3 downregulation and CD69 and
assay with R-phycoerythrin-labeled streptavidin (SA-PE) tetramers CD25 upregulation (Figure 3, dashed lines) and com-
(35 nM) carrying HLA-DR1-Ha peptide complexes. In both (A) and peted efficiently for T cell receptor binding with an IC50(B), monomers (closed circles) were able to bind to HA1.7 T cells
of z17 nM (Figure 4B, dashed line). Extrapolation of theunder conditions where no activation was observed. Tetramers
log-linear relationship of IC50 with oligomer size ob-(closed squares) bound better than trimers (closed triangles), and
trimers bound better than dimers (closed diamonds). Higher order served for the chemically defined reagents suggests a
SA oligomer binding (X) is indicated by a dotted line. No binding nominal oligomer size of six for the SA oligomers (see
was observed with tetramers or monomers carrying the nonspecific Experimental Procedures). Figure 5A shows correlation
peptide A2 (open squares, open circles). of the levels of CD69 activation with TCR downregula-
tion, and Figure 5B shows correlation of CD25 activation
with TCR downregulation. In these plots we includedMHC monomers exhibited a clear antigen-specific bind-
data for streptavidin oligomers along with those foring signal. Tetramers and monomers carrying HLA-DR1
chemically defined dimers, trimers, and tetramers. Thecomplexes of the nonspecific peptide A2 did not bind.
relationship between CD69 upregulation and TCR down-Thus, MHC monomers and oligomers both bind effi-
regulation appears roughly linear (correlation coefficientciently to antigen-specific T cells under the conditions
0.92), while the relationship between CD25 upregulationof the activation assays. However, quantitative interpre-
and TCR downregulation appears curved. Althoughtation of cross-linker fluorescence intensity in terms of
there is substantial scatter in the plots, the points de-MHC-TCR affinity was complicated by internalization of
scribing the activation induced by each of the differentlabeled MHC monomers and oligomers during the
oligomers clearly follow the same relationship. This indi-course of the assay (T. O. C., unpublished data). As a
cates that the relative activation of the various pathwaysresult of this internalization, the levels of cell-associated
is the same for each of the oligomers, with binding offluorescence did not saturate at high concentrations.
a fewer number of larger oligomers indistinguishableAlthough we could not use the direct binding data to
from binding of a larger number of smaller oligomers.determine binding affinities, these data were very useful
Thus, the quality of the activation signal induced byin correlating levels of T cell activation with numbers of
oligomer binding is analogous, regardless of the valencyMHC bound for the various oligomers (see below).
or chemical nature of the oligomer used to stimulate theTo measure the relative avidity of oligomer binding
T cell.without complications arising from internalization, a
competition assay was used (Figure 4B). R-phycoer-
ythrin-labeled streptavidin-cross-linked (SA-PE) ªtetra- Correlation of Binding with Activation
Having measured binding data concurrently with T cellmersº of biotinylated MHC-peptide complexes (Altman
et al., 1996; Crawford et al., 1998) were used as a binding activation, we were able to differentiate avidity effects
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Figure 5. Correlation of T Cell Activation Markers
TCR downregulation plotted against the cell surface expression of
CD69 (A) or CD25 (B) observed during the same experiment. Sym-
bols for the various MHC oligomers are as used in the previous
figures. Plots are representative of data from several experiments.
from any intrinsic differences in the ability of the bound
oligomers to activate T cells. We observed a striking
correlation between the level of activation and the num-
ber of MHC molecules engaged per cell, calculated from
oligomer direct binding data and the number of MHC
molecules per oligomer (Figure 6). For each of the T Figure 6. Correlation of MHC Binding and T Cell Activation
cell activation assays, the curves describing the binding The number of MHC molecules bound (determined by direct binding
measurement) was plotted against T cell activation for CD69 at 12activity relationships for MHC dimers, trimers, and tetra-
hr (A) and for CD3 (B) and CD25 (C) at 27 hr. Dotted lines and openmers nearly overlap. At high oligomer concentrations,
symbols indicate regions (above 1 mM) of the activation plots (Figurethe activation levels decreased with increasing oligomer
3) in which increasing oligomer concentration caused decreasingconcentration (Figure 3) as a result of a saturation effect
activation. At lower concentrations, tetramers (squares), trimers (tri-
that lowers the effective binding valency and avidity angles), and dimers (diamonds) appeared to follow the same depen-
under conditions where a large fraction of the receptor dence. Monomers (circles) bound but did not cause substantial
activation. For oligomers, binding was measured concurrently withare occupied (Lauffenburger and Linderman, 1993). The
activation markers. For monomers, levels of binding for labeledsame phenomenon leads to monovalent antibody bind-
preparations were compared with the activation level induced bying at high antibody/antigen ratios. These regimes are
unlabeled preparations at the same concentration. Data are repre-indicated with open symbols and dashed lines in Figure
sentative of several experiments.
6. For the monomers, the curves describing the binding
activity relationships are essentially flat and clearly dis-
tinct from those of the other oligomers. The dramatically Discussion
different dependence observed for the monomers con-
firms that monomers can bind to T cells without inducing Dimer Formation Is Necessary and Sufficient
for Activation of HA1.7 CD41 T Cellsactivation. For the oligomers, the similarity of the curves
for the various oligomers indicates that the T cell is by MHC Oligomers
T cell activation in vivo involves many coupled cellularresponding to the number of MHC molecules engaged
in oligomeric complexes, regardless of the size of the processes occurring over time scales from seconds to
days (Ullman et al., 1990), and the nature of the activationoligomer. These results can be used to evaluate possible
molecular mechanisms for the T cell activation process, response can vary depending on the history and devel-
opmental state of both the antigen-presenting cell andas discussed below.
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the T cell (Constant and Bottomly, 1997; Dutton et al., Implications for the Mechanism of T Cell Activation
The results presented in this manuscript can be used1998). In this work we have investigated the molecular
requirements for the initial, membrane-proximal trig- to evaluate possible molecular mechanisms for the initial
triggering event in the activation of T cells by MHC-gering event, using a well-characterized Th0 memory T
cell clone specific for an influenza hemagglutinin peptide peptide complexes. T cell activation was not induced by
MHC-peptide monomers, even under conditions where(Ha) bound to the human class II MHC molecule HLA-
DR1 (Lamb et al., 1982). We find that soluble MHC oligo- most of the TCR molecules were engaged by MHC-
peptide complexes. Thus, processes activated by for-mers are able to activate several conventional activation
processes, including those that require membrane-to- mation of the MHC-TCR complex per se appear to be
ruled out or made less likely as key components ofnucleus signaling. Costimulation through other signaling
pathways (Mueller et al., 1989) may be required in addi- the triggering mechanism. These include conformational
(Janeway, 1995), allosteric (Alam et al., 1999), or oligo-tion to the initial MHC-TCR triggering event for entry
into the cell cycle and induction of the full range of meric (Reich et al., 1997) changes that may be induced
in TCR molecules as a result of binding monomericeffector responses characteristic of interaction with an
antigen-presenting cell. MHC-peptide complexes. Similarly, heterooligomeriza-
tion processes, in which cytoplasmic signaling eventsA dimer is the minimal oligomer size required for acti-
vation of HA1.7 T cells by soluble MHC oligomers, as are activated by simultaneous binding of a single MHC-
peptide complex to a TCR molecule carrying signalingjudged by upregulation of the early activation marker
CD69 and the low-affinity IL-2 receptor CD25, and inter- targets (such as CD3 gde and z2 ITAMs) and to another
T cell protein carrying an enzymatic activity (such asnalization of activated TCR CD3 subunits. Monomers
were inactive in all assays, although they were shown CD4-lck) (Chan et al., 1994; Delon et al., 1998), appear
to be ruled out as triggering mechanisms by the inabilityto bind to T cells in an antigen-specific manner and
occupy a substantial fraction of T cell receptors. Al- of bound MHC monomers to initiate activation. How-
ever, it is conceivable that monomeric binding on a cellthough higher valency oligomers were more potent in
activating T cells, this increased potency was due to surface might initiate partial signals not sufficient to
initiate activation processes unless coupled with othertheir increased binding avidity. In a previous study (Boni-
face et al., 1998), the minimal T cell activity shown for stimuli. While CD8 might be participating in heterooli-
gomerization of MHC-TCR in class I MHC-restricted Tstreptavidin-linked MHC dimers as compared to trimers
and tetramers may have been due to their much lower cell responses reported to be initiated by monomeric
engagement (Sykulev et al., 1996; Delon et al., 1998),binding avidity. In our system, quantitative analysis
demonstrated that per MHC molecule bound, the dimers CD4 does not appear to have such a role in the CD41
HA1.7 T cells that we investigated here. In this system,were just as effective as the trimers or the tetramers in
activating T cells. To the extent that induction of T cell our results demonstrate that monomeric engagement
alone clearly is not sufficient to initiate T cell activation.activation by soluble MHC oligomers is representative
of T cell activation in general, these results would sug- Large scale reorganizations of T cell membrane pro-
tein and lipid components have been shown to accom-gest that bridging two T cell receptor molecules is a
necessary and sufficient event for triggering T cell acti- pany T cell activation (Monks et al., 1998; Moran and
Miceli, 1998; Xavier et al., 1998; Grakoui et al., 1999;vation and that the bridged TCRs are equally efficient
in stimulating T cell activation whether they are in a Janes et al., 1999; Viola et al., 1999). In one particular
model proposed for the coupling of such membranecluster of two, three, or four receptors.
The sets of dose-response curves for T cell activation reorganizations to molecular activation processes,
close apposition of T cell and antigen-presenting cellby MHC oligomers (Figure 3) are similar to those pre-
dicted by a mathematical model of a system responsive membranes, bridged by the relatively small MHC and
TCR molecules, acts to exclude large negative regula-to the number of receptor cross-links induced by
multivalent ligands of varying sizes (Perelson and DeLisi, tors such as the tyrosine phosphatase CD45, resulting in
increased receptor phosphorylation (Shaw and Dustin,1980; Lauffenburger and Linderman, 1993). In this
model, a bound dimer contributes one cross-link, a 1997). Our data would appear to rule out such molecular
exclusions as the proximal triggering event, at least forbound trimer contributes two cross-links, and in general
a bound N-mer contributes N-1 cross-links. In Figure the T cell activation processes investigated here, as it
is not likely that the binding of soluble MHC dimers3, the distinct maximum observed in each curve, with
decreasing activation observed at high concentration, would exclude other proteins from the local region of
membrane. If supramolecular receptor clustering andthe dependence of the half-maximal concentration on
the oligomer size, and the dependence of the maximum interaction with lipid microdomains do play a key role
in the initial signaling processes that we examined, theylevel of activation on the oligomer size are all predicted
by this model. What molecular event could correspond must occur downstream of dimerization-initiated signal-
ing events and by a mechanism available to solubleto the two ªcross-linksº induced by binding an MHC
trimer? If engaged TCR molecules formed stable dimers, oligomers in the absence of costimulatory molecules.
Our results are consistent with a mechanism for ana bound MHC trimer could engage only one cross-linked
TCR dimer. However, if TCR dimers were transient spe- initial activation process in which multivalent engage-
ment of MHC-peptide complexes causes dimerizationcies, a bound MHC trimer could serially engage multiple
TCR dimers. In this scenario, the T cell responds to the of TCR molecules (Brown et al., 1993; Germain, 1993)
or rearrangement of existing TCR dimers (Fernandez-serial dimerization of its receptors on the bound MHC
oligomer. Miguel et al., 1999). This could occur without significant
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unpublished data). The introduced cysteines undergo facile reactionconformational change within an individual TCR mole-
with thiol-specific reagents, allowing specific cross-linking at the acule but rather by intermolecular reorientation, as sug-
or b subunit termini.gested in a recent structural characterization of MHC-
TCR complexes (Ding et al., 1999). Binding of MHC
Peptide-Based Cross-Linking Reagents
oligomers, or MHC molecules constrained to be in the Peptides were synthesized by FMOC chemistry using an Advanced
same membrane as on the surface an antigen-present- ChemTech 357 FBS combinatorial peptide synthesizer. After synthe-
sis, the N terminus was capped by reaction with fluorescein isothio-ing cell, could allow preexisting TCR dimers to reorga-
cyanate (FITC) or a long-chain succinimide ester of biotin (NHS-LC-nize into an active form by allosteric rearrangement of
LC-biotin, Pierce). Peptides were purified by reverse phase HPLCTCR subunits. For either preexisting TCR dimers or ligand-
using a C4 or C18 column (Vydac) and verified using MALDI-TOF.induced dimerization, the binding-dependent rearrange-
Purified peptides were reacted through the e-amino group of lysine
ment could promote tyrosine phosphorylation of TCR residues with either N-[e-Maleimidocaproyloxy]succinimide ester
subunits or transphosphorylation of associated kinases, (EMCS, Pierce) or succinimidyl-4-[N-maleimidomethyl]-cyclohex-
ane-1-carboxy-[6- amidocaproate] (LC-SMCC, Pierce) by dissolvingas observed in other dimerization-responsive systems
excess reagent in DMF and adding it to peptide in 10 mM Na-(Klemm et al., 1998).
phosphate buffer (pH 7) and 150 mM NaCl. After 1.5 hr at roomAt low oligomer concentrations, we observed down-
temperature, the modified peptide was purified by reverse-phaseregulation of multiple TCR per MHC molecule bound
HPLC. The presence of the appropriate number of maleimide func-
(Figure 6B), in an apparent serial triggering phenomenon tional groups to make dimers, trimers, and tetramers was confirmed
as first observed by Valitutti et al. (1995). Serial triggering by MALDI-TOF. Estimated maleimide-to-maleimide distances for
the cross-linkers in a fully extended conformation would be approxi-provides greater sensitivity to the system at lower ligand
mately 20 AÊ for the dimeric cross-linker and 28 AÊ for the trimericlevels (Valitutti and Lanzavecchia, 1997), which leads to
and tetrameric cross-linkers.a hyperbolic binding versus activation profile, as ob-
served for CD3 downregulation (Figure 6B). This effect
Cross-Linking of Soluble MHC-Peptide Complexes
is particularly prominent in the CD69 upregulation profile Chemical cross-links were made through the introduced sulfhydryl
(Figure 6A). The molecular mechanism for serial engage- group on the b chain of the MHC-peptide complex and the thiol-
ment by soluble MHC oligomers would appear to involve specific maleimide group on the peptide-based cross-linkers.
Cross-linker was titrated step-wise into purified cysteine-modifiedrelease and rebinding of TCR by MHC molecules that
HLA-DR1 in 10 mM Na-phosphate buffer (pH 7), 150 mM NaCl, andare constrained to the surface through interactions of
5 mM EDTA. Extent of cross-linking, measured by SDS-PAGE, variedother components in the same oligomer. We note that
from approximately 60% for the dimers to 25% for the tetramers.
such a mechanism would allow ªherdingº of receptors Cross-linked MHC-peptide complexes were isolated by gel filtration
into an activated cluster and might be similar to pro- using two Superdex 200 FPLC columns (Pharmacia) in series. Purity
cesses occurring at the juxtaposed membranes of an was determined by 10% SDS-PAGE.
antigen-presenting cell and a T cell.
Streptavidin-Based OligomersIn conclusion, we have used a series of chemically
For R-phycoerythrin-labeled streptavidin-linked (SA-PE) tetramers,defined oligomers of MHC-peptide complexes to probe
the free sulfhydryl on the a chain of the DR1 peptide complex wasthe requirements for T cell activation. We find that mono-
reacted with biotin PEO-maleimide (Pierce) and the excess biotin
mers are unable to activate T cells even under conditions removed by gel filtration. The biotinylated MHC-peptide complex
where they engage a substantial fraction of available T was then reacted in a slight molar excess with R-PE-labeled strep-
cell receptors, whereas MHC dimers, trimers, and tetra- tavidin (Sigma) to give a mixture of mostly tetramer and trimer. For
higher order streptavidin-linked oligomers, a biotinylated dimer ofmers all activate efficiently. The extent and nature of the
MHC-peptide complexes was made using the peptide-based cross-activation signal induced by binding of these oligomers
linker shown in Figure 1B and the free sulfhydryl on the a chain.appears to be equivalent regardless of the oligomer size,
Biotinylated dimer was separated from free monomer and cross-
suggesting that an initial step in the T cell activation linker using Superdex 200 FPLC and was reacted with streptavidin
mechanism is the formation or rearrangement of a dimer as above. The effective oligomer size of the streptavidin-linked
of T cell receptor molecules, and that a T cell responds oligomer of MHC dimers was approximately six, as estimated by
extrapolation of the binding IC50 versus oligomer size dependenceto the number of TCR cross-links induced at the surface.
(see below). Estimated maleimide-to-biotin distances are approxi-
mately 35 AÊ for the biotinylated dimer.Experimental Procedures
MHC-Peptide MonomersMHC-Peptide Complexes
In activation and competitive binding experiments, we used solubleSoluble MHC-peptide complexes were produced by expression of
HLA-DR1 that did not carry an introduced cysteine residue. In prepa-the extracellular portions of HLA-DRA1*0101 (a1±182) and HLA-
rations of monomers carrying the introduced cysteine, we could notDRB1*0101 (b1±190) (SwissProt: P01903, P13758) in E. coli followed
avoid adventitious dimerization of a small fraction of moleculesby folding in vitro in the presence of peptide (Frayser et al., 1999).
(,1%) due to air oxidation and disulfide bond formation, whichAntigenic peptide Ha[306±318] (PKYVKQNTLKLAT), derived from
complicated activation experiments at high monomer concentra-influenza virus hemagglutinin, and control endogenous peptide
tions. For the direct binding experiments, FITC-labeled monomerHLA-A2[103±117] (VGSDWRFLRGYHQYA), were synthesized using
was prepared by reaction of HLA-DR1 carrying an a chain freeFMOC chemistry, purified by reverse phase HPLC, and verified by
cysteine with fluorescein-maleimide (Pierce) followed by purificationmass spectrometry (MALDI-TOF). For cross-linking, Ala±Cys se-
with gel filtration chromatography. Any possible dimerized fractionquences were added individually after the ªconnecting peptideº
in this preparation would not be labeled.regions a183±192 or b191±198. Cysteine modified complexes were
purified in the presence of 5 mM dithiothreitol, which was removed
immediately prior to cross-linking. The introduced cysteine residues T Cell Clones
The human CD41 T cell clone HA1.7 (Lamb et al., 1982) was culturedare uniquely reactive, as the other seven HLA-DR1 cysteines are
involved in disulfide bonds (a108±164, b16±79, b118±174) or seques- in RPMI, 5% human serum, 5% fetal bovine serum, and was stimu-
lated every 2 weeks with 120 IU/ml IL-2 (Intergen) and an irradiatedtered from solvent (b30) by the bound peptide and are unreactive
with thiol-specific maleimide or pyridyl disulfide probes (J. R. C., mixture of peripheral blood lymphocytes and EBV1.24, a DR11 B
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cell line, pulsed with 1 mM Ha peptide. T cells were rested a minimum Differential signaling by lymphocyte antigen receptors. Annu. Rev.
Immunol. 15, 125±54.of 12 days before use in activation assays.
Altman, J.D., Moss, P.A.H., Goulder, P.J.R., Barouch, D.H.,
McHeyzer-Williams, M.G., Bell, J.I., McMichael, A.J., and Davis,T Cell Activation Assays
M.M. (1996). Phenotypic analysis of antigen-specific T lymphocytes.MHC-peptide oligomers were added to 7.5 3 104 HA1.7 T cells in
Science 274, 94±96.round-bottom 96-well plates and incubated at 378C, 5% CO2. After
the indicated times, cells were placed in ice and stained concurrently Bekoff, M., Kubo, R., and Grey, H.M. (1986). Activation requirements
with R-phycoerythrin-labeled CD3 (UCHT-1, Sigma) and either allo- for normal T cells: accessory cell-dependent and -independent stim-
phycocyanin-labeled CD69 or CD25 (FN50 or M-A251, PharMingen) ulation by anti-receptor antibodies. J. Immunol. 137, 1411±1419.
for 1 hr at 48C. Cells were washed with PBS containing 1% fetal Boniface, J.J., Rabinowitz, J.D., Wulfing, C., Hampl, J., Reich, Z.,
bovine serum and 0.1% sodium azide and analyzed by flow cytome- Altman, J.D., Kantor, R.M., Beeson, C., McConnell, H.M., and Davis,
try. Fluorescence data were obtained with a Becton-Dickinson FAC- M.M. (1998). Initiation of signal transduction through the T cell recep-
Scalibur flow cytometer and analyzed using Cell Quest software. tor requires the multivalent engagement of peptide/MHC ligands.
Number of CD3 molecules per cell was converted from mean fluores- Immunity 9, 459±466.
cence PE using SPHERO Rainbow Calibration particles (Sphero-
Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G.,
tech) containing known amounts of PE equivalents.
Strominger, J.L., and Wiley, D.C. (1993). Three-dimensional structure
of the human class II histocompatibility antigen HLA-DR1. Nature
Oligomer Binding Assay 364, 33±39.
For the direct binding assay, levels of cell-associated fluorescence Cantrell, D. (1996). T cell antigen receptor signal transduction path-
were measured simultaneously with the activation markers by ways. Annu. Rev. Immunol. 14, 259±274.
multicolor flow cytometry using the fluorescein labels incorporated
Caruso, A., Licenziati, S., Corulli, M., Canaris, A.D., De Francesco,into the synthetic cross-linkers or monomeric DR1. Mean fluores-
M.A., Fiorentini, S., Peroni, L., Fallacara, F., Dima, F., Balsari, A.,cence intensity was converted to numbers of fluorescein molecules
and Turano, A. (1997). Flow cytometric analysis of activation markersper cell using SPHERO Rainbow Calibration particles (Spherotech).
on stimulated T cells and their correlation with cell proliferation.For comparison with activation levels, concentrations of bound
Cytometry 27, 71±76.oligomers were converted to concentration of bound MHC mole-
Casares, S., Zong, C.S., Radu, D.L., Miller, A., Bona, C.A., and Bru-cules using the known valency of the cross-linkers. Fluorescence
meanu, T.D. (1999). Antigen-specific signaling by a soluble, dimericlevels in this assay reflect the number of molecules bound at the
peptide/major histocompatibility complex class II/Fc chimera lead-cell surface as well as those taken up into the cell (T. O. C., unpub-
ing to T helper cell type 2 differentiation. J. Exp. Med. 190, 543±554.lished data). Fluorescence signals from molecules internalized to
Chan, A.C., Desai, D.M., and Weiss, A. (1994). The role of proteinacidic compartments may have reduced intensity due to the intrinsic
tyrosine kinases and protein tyrosine phosphatases in T cell antigenpH dependence of fluorescein fluorescence intensity. This effect
receptor signal transduction. Annu. Rev. Immunol. 12, 555±592.was not considered in the calibration procedure but is presumed
to be equivalent for all of the oligomers. Constant, S.L., and Bottomly, K. (1997). Induction of Th1 and Th2
For the competition assay, various concentrations of MHC oligo- CD41 T cell responses: the alternative approaches. Annu. Rev.
mers or unlabeled MHC monomer were added to 7.5 3 104 HA1.7 Immunol. 15, 297±322.
T cells containing a constant amount of phycoerythrin-labeled SA Crawford, F., Kozono, H., White, J., Marrack, P., and Kappler, J.
tetramer (SA-PE, 35 nM) in 96-well round-bottom plates and incu- (1998). Detection of antigen-specific T cells with multivalent soluble
bated for 3 hr at 378C, 5% CO2. Fluorescence arising from bound SA- class II MHC covalent peptide complexes. Immunity 8, 675±682.
PE was measured by flow cytometry. IC50 values were determined as Davis, M.M., Boniface, J.J., Reich, Z., Lyons, D., Hampl, J., Arden,
the concentration of unlabeled oligomer required to reduce the level
B., and Chien, Y. (1998). Ligand recognition by alpha beta T cell
of SA-PE tetramer staining by one-half. For the chemically defined
receptors. Annu. Rev. Immunol. 16, 523±544.
MHC oligomers and monomer, the IC50 values were logarithmically
Delon, J., Gregoire, C., Malissen, B., Darche, S., Lemaitre, F., Kouril-related to the oligomer size n as follows: 2log IC50 5 0.54n 1 4.84
sky, P., Abastado, J.P., and Trautmann, A. (1998). CD8 expression(R 5 0.986). Upon extrapolation of this dependence, the measured
allows T cell signaling by monomeric peptide-MHC complexes. Im-IC50 for the SA-linked oligomer of MHC dimers yields an effective
munity 9, 467±473.oligomer size of six (5.4 6 0.8).
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